propofol has been researched along with Autism Spectrum Disorder in 2 studies
Propofol: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
propofol : A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group.
Autism Spectrum Disorder: Wide continuum of associated cognitive and neurobehavioral disorders, including, but not limited to, three core-defining features: impairments in socialization, impairments in verbal and nonverbal communication, and restricted and repetitive patterns of behaviors. (from DSM-V)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To quantify the number of personnel, time to induce and complete sedation using propofol for outpatient magnetic resonance imaging (MRI) of the brain, and the frequency of serious adverse events (SAEs) in children with autism spectrum disorder (ASD) compared with children without ASD." | 7.88 | Outpatient Procedural Sedation of Patients With Autism Spectrum Disorders for Magnetic Resonance Imaging of the Brain Using Propofol. ( Grunwell, JR; Kamat, PP; Karaga, MK; McCracken, CE; Sidhu, R; Simon, HK; Wisniewski, BL, 2018) |
| " Both propofol and dexmedetomidine proved to be adequate and safe medications in the sedation of autistic children undergoing MRI." | 5.48 | A Comparison of Safety and Efficacy of Dexmedetomidine and Propofol in Children with Autism and Autism Spectrum Disorders Undergoing Magnetic Resonance Imaging. ( Abulebda, K; Ahmed, SS; Louer, R; Lutfi, R, 2018) |
| " Both propofol and dexmedetomidine proved to be adequate and safe medications in the sedation of autistic children undergoing MRI." | 1.48 | A Comparison of Safety and Efficacy of Dexmedetomidine and Propofol in Children with Autism and Autism Spectrum Disorders Undergoing Magnetic Resonance Imaging. ( Abulebda, K; Ahmed, SS; Louer, R; Lutfi, R, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kamat, PP | 1 |
| Karaga, MK | 1 |
| Wisniewski, BL | 1 |
| McCracken, CE | 1 |
| Simon, HK | 1 |
| Sidhu, R | 1 |
| Grunwell, JR | 1 |
| Abulebda, K | 1 |
| Louer, R | 1 |
| Lutfi, R | 1 |
| Ahmed, SS | 1 |
2 other studies available for propofol and Autism Spectrum Disorder
| Article | Year |
|---|---|
Outpatient Procedural Sedation of Patients With Autism Spectrum Disorders for Magnetic Resonance Imaging of the Brain Using Propofol.
Topics: Ambulatory Care; Autism Spectrum Disorder; Brain; Case-Control Studies; Child; Clinical Protocols; F | 2018 |
A Comparison of Safety and Efficacy of Dexmedetomidine and Propofol in Children with Autism and Autism Spectrum Disorders Undergoing Magnetic Resonance Imaging.
Topics: Anesthesia, Intravenous; Autism Spectrum Disorder; Child; Child, Preschool; Dexmedetomidine; Female; | 2018 |